Judgment of the General Court (Ninth Chamber) of 8 September 2016.#H. Lundbeck A/S and Lundbeck Ltd v European Commission.#Competition — Agreements, decisions and concerted practices — Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram — Concept of restriction of competition ‘by object’ — Potential competition — Generic medicinal products — Barriers to market entry resulting from the existence of patents — Agreements concluded between a patent holder and generic undertakings — Article 101(1) and (3) TFEU — Errors of law and of assessment — Obligation to state reasons — Rights of defence — Legal certainty — Fines.#Case T-472/13.

Records

Official record CELEX 62013TJ0472 from European Union at Court of Justice of the European Union. Dated 8 September 2016. Status: decided.

Timeline

1. 8 September 2016

   Decided

   Source: work_date_document

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Judgment of the General Court (Ninth Chamber) of 8 September 2016.#H. Lundbeck A/S and Lundbeck Ltd v European Commission.#Competition — Agreements, decisions and concerted practices — Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram — Concept of restriction of competition ‘by object’ — Potential competition — Generic medicinal products — Barriers to market entry resulting from the existence of patents — Agreements concluded between a patent holder and generic undertakings — Article 101(1) and (3) TFEU — Errors of law and of assessment — Obligation to state reasons — Rights of defence — Legal certainty — Fines.#Case T-472/13.

  judgment · EN · 8 September 2016

  ViewDownloadOpen at official source

Sponsors

• · GCEU · General Court

Related records

No cross-record relationships stored yet.